Cafepharma Today

June 4 2025 - Moderna will test new COVID shot against placebo, Robert F Kennedy Jr. says
Moderna will test new COVID shot against placebo, Robert F Kennedy Jr. says
Massachusetts’ life sciences job growth flattens after 10+ years of increases
CDC official overseeing COVID-19 vaccine recommendations resigns
Lilly inks deal worth up to $870M to develop long-acting GLP-1 obesity drugs
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Obesity Stocks Focus on Approvals As Arena Pharmaceuticals Goes Global
TheStreet.com
Monday, January 6, 2014 - 7:26pm
tags:
drug approvals, Arena Pharmaceuticals, obesity, GSK, Orexigen, Belviq, Eisai
Neurocrine Biosciences shares surge on study
Marketwatch
Monday, January 6, 2014 - 4:58pm
tags:
tardive dyskinesia, Neurocrine Biosciences, NBI-98854
FDA returns for look at risk of Boehringer Ingelheim's Pradaxa
Fierce Pharma
Monday, January 6, 2014 - 4:53pm
tags:
Pradaxa, FDA, Boehringer Ingelheim, bloodthinners
Intercept to Provide Update on Pipeline
Yahoo/Zacks.com
Monday, January 6, 2014 - 4:49pm
tags:
Intercept Pharma, primary biliary cirrhosis
Three biopharma companies poised for product OKs in 2014: analyst
Marketwatch
Monday, January 6, 2014 - 4:34pm
tags:
Cubist, Regeneron, Spectrum
This FDA Letter About Sarepta and Accelerated Approval for Eteplirsen Will Blow Your Mind
TheStreet.com
Monday, January 6, 2014 - 4:25pm
tags:
FDA, Sarepta Therapeutics, Duchenne Muscular Dystrophy, eteplirsen
Is Cell Therapeutics Turning Over A New Leaf In 2014?
Wall St Cheat Sheet
Monday, January 6, 2014 - 11:51am
tags:
Cell Therapeutics, tosedostat
Cancer Drug Royalties: Celgene Battles Boston Hospital
Wall St Cheat Sheet
Monday, January 6, 2014 - 11:45am
tags:
Celgene
Semantics 101: Goldman’s Biotech Downgrade and the New Biotech Consensus
Barron's
Monday, January 6, 2014 - 11:44am
tags:
biotech, Amgen, Regeneron
J&J's Synthes wins round in spat with ex-sales rep
Mass Device
Monday, January 6, 2014 - 11:05am
tags:
devices, JNJ, Synthes
Is the audience listening? FDA wants to spy on social media to find out
Fierce Pharma
Monday, January 6, 2014 - 11:03am
tags:
FDA, social media
India - An important Market for Mylan
Yahoo/Zacks.com
Monday, January 6, 2014 - 10:57am
tags:
India, Mylan
FIT Biotech to begin HIV vaccine trial in spring 2014
Pharmaceutical Business Review
Monday, January 6, 2014 - 9:59am
tags:
HIV, FIT Biotech, vaccines
The Surprising Way Big Pharma Is Researching New Drugs
Motley Fool
Monday, January 6, 2014 - 9:58am
tags:
Amgen, R&D
BrainStorm Cell Therapeutics says stem cells helped patient with ALS and MG
Reuters
Monday, January 6, 2014 - 9:55am
tags:
ALS, BrainStorm Cell Therapeutics, stem cells, myasthenia gravis
Thermo Fisher sells cell culture, other businesses to GE
Yahoo/Reuters
Monday, January 6, 2014 - 9:51am
tags:
Thermo Fisher, devices, General Electric, M&A, cell culture, magnetic beads, gene modulation
J&J gambles $12.5M in rare Big Pharma bet on a stem cell therapy
Fierce Biotech
Monday, January 6, 2014 - 9:49am
tags:
JNJ, stem cells, Capricor
22 Biotech Stock Predictions for 2014
TheStreet.com
Monday, January 6, 2014 - 9:47am
tags:
biotech, Vertex Pharmaceuticals, Orexigen, Retrophin, Valeant Pharmaceuticals, Questcor, Biomarin, Merck, NeoStem, Amgen, Gilead Sciences, Vanda, Keryx, Peregrine Pharmaceuticals, CelSci, Regeneron, Cempra, Dendreon, Clovis Oncology, Halozyme, NPS Pharmaceuticals
MannKind Corporation: One Large Step For Shareholders, One Gigantic Step For Diabetics
Seeking Alpha
Monday, January 6, 2014 - 9:43am
tags:
MannKind, diabetes, Afrezza
Gene Patent Case Fuels U.S. Court Test of Stem Cell Right
Bloomberg
Monday, January 6, 2014 - 9:42am
tags:
patents, stem cells, genes

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.